
|Videos|September 8, 2022
Brexucabtagene Autoleucel in Mantle Cell Lymphoma
Andre Goy, MD, and Andrew Ip, MD, give an overview of the approval of CAR T-cell therapy for mantle cell lymphoma treatment.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
2
Current Treatment Landscape of HER2-Positive Metastatic Breast Cancer and Phase 3 Trial Overview
3
How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment?
4
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
5
















































































